Logo image of ALNSE.PA

NSE (ALNSE.PA) Stock Fundamental Analysis

EPA:ALNSE - Euronext Paris - Matif - FR0004065639 - Common Stock - Currency: EUR

47  +0.4 (+0.86%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ALNSE. ALNSE was compared to 46 industry peers in the Aerospace & Defense industry. ALNSE has an excellent financial health rating, but there are some minor concerns on its profitability. ALNSE has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ALNSE was profitable.
In the past year ALNSE had a positive cash flow from operations.
ALNSE had positive earnings in each of the past 5 years.
ALNSE had a positive operating cash flow in 4 of the past 5 years.
ALNSE.PA Yearly Net Income VS EBIT VS OCF VS FCFALNSE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.15%, ALNSE is in the better half of the industry, outperforming 62.22% of the companies in the same industry.
ALNSE has a Return On Equity (8.69%) which is comparable to the rest of the industry.
ALNSE has a Return On Invested Capital of 10.97%. This is in the better half of the industry: ALNSE outperforms 77.78% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALNSE is in line with the industry average of 8.98%.
The last Return On Invested Capital (10.97%) for ALNSE is above the 3 year average (9.24%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.15%
ROE 8.69%
ROIC 10.97%
ROA(3y)4.86%
ROA(5y)5.44%
ROE(3y)9.24%
ROE(5y)10.68%
ROIC(3y)9.24%
ROIC(5y)10.98%
ALNSE.PA Yearly ROA, ROE, ROICALNSE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

1.3 Margins

The Profit Margin of ALNSE (3.50%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of ALNSE has declined.
Looking at the Operating Margin, with a value of 6.85%, ALNSE is doing worse than 60.00% of the companies in the same industry.
In the last couple of years the Operating Margin of ALNSE has declined.
With a decent Gross Margin value of 43.87%, ALNSE is doing good in the industry, outperforming 71.11% of the companies in the same industry.
ALNSE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.85%
PM (TTM) 3.5%
GM 43.87%
OM growth 3Y-10.36%
OM growth 5Y-11.66%
PM growth 3Y-17.04%
PM growth 5Y-14.59%
GM growth 3Y-13.53%
GM growth 5Y-7.43%
ALNSE.PA Yearly Profit, Operating, Gross MarginsALNSE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ALNSE is still creating some value.
ALNSE has about the same amout of shares outstanding than it did 1 year ago.
ALNSE has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ALNSE has been reduced compared to a year ago.
ALNSE.PA Yearly Shares OutstandingALNSE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALNSE.PA Yearly Total Debt VS Total AssetsALNSE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

ALNSE has an Altman-Z score of 4.53. This indicates that ALNSE is financially healthy and has little risk of bankruptcy at the moment.
ALNSE's Altman-Z score of 4.53 is amongst the best of the industry. ALNSE outperforms 82.22% of its industry peers.
ALNSE has a debt to FCF ratio of 0.65. This is a very positive value and a sign of high solvency as it would only need 0.65 years to pay back of all of its debts.
ALNSE's Debt to FCF ratio of 0.65 is amongst the best of the industry. ALNSE outperforms 93.33% of its industry peers.
A Debt/Equity ratio of 0.12 indicates that ALNSE is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.12, ALNSE belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 0.65
Altman-Z 4.53
ROIC/WACC1.41
WACC7.78%
ALNSE.PA Yearly LT Debt VS Equity VS FCFALNSE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

ALNSE has a Current Ratio of 1.77. This is a normal value and indicates that ALNSE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.77, ALNSE is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
ALNSE has a Quick Ratio of 1.31. This is a normal value and indicates that ALNSE is financially healthy and should not expect problems in meeting its short term obligations.
ALNSE's Quick ratio of 1.31 is amongst the best of the industry. ALNSE outperforms 82.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.31
ALNSE.PA Yearly Current Assets VS Current LiabilitesALNSE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

6

3. Growth

3.1 Past

The earnings per share for ALNSE have decreased strongly by -12.26% in the last year.
The Earnings Per Share has been decreasing by -9.31% on average over the past years.
The Revenue has grown by 34.51% in the past year. This is a very strong growth!
Measured over the past years, ALNSE shows a small growth in Revenue. The Revenue has been growing by 6.37% on average per year.
EPS 1Y (TTM)-12.26%
EPS 3Y-3.88%
EPS 5Y-9.31%
EPS Q2Q%-59.8%
Revenue 1Y (TTM)34.51%
Revenue growth 3Y15.84%
Revenue growth 5Y6.37%
Sales Q2Q%16.05%

3.2 Future

The Earnings Per Share is expected to grow by 21.28% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 17.73% on average over the next years. This is quite good.
EPS Next Y25.09%
EPS Next 2Y21.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year33.7%
Revenue Next 2Y17.73%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALNSE.PA Yearly Revenue VS EstimatesALNSE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
ALNSE.PA Yearly EPS VS EstimatesALNSE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5 2

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 41.23 indicates a quite expensive valuation of ALNSE.
Compared to the rest of the industry, the Price/Earnings ratio of ALNSE is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.50, ALNSE is valued a bit more expensive.
A Price/Forward Earnings ratio of 25.07 indicates a quite expensive valuation of ALNSE.
62.22% of the companies in the same industry are more expensive than ALNSE, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.44, ALNSE is valued a bit cheaper.
Industry RankSector Rank
PE 41.23
Fwd PE 25.07
ALNSE.PA Price Earnings VS Forward Price EarningsALNSE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALNSE indicates a rather cheap valuation: ALNSE is cheaper than 84.44% of the companies listed in the same industry.
93.33% of the companies in the same industry are more expensive than ALNSE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.1
EV/EBITDA 13.84
ALNSE.PA Per share dataALNSE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

ALNSE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ALNSE's earnings are expected to grow with 21.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.64
PEG (5Y)N/A
EPS Next 2Y21.28%
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.58%, ALNSE is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.11, ALNSE has a dividend in line with its industry peers.
With a Dividend Yield of 0.58, ALNSE pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 0.58%

5.2 History

The dividend of ALNSE is nicely growing with an annual growth rate of 22.60%!
Dividend Growth(5Y)22.6%
Div Incr Years2
Div Non Decr Years5
ALNSE.PA Yearly Dividends per shareALNSE.PA Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

ALNSE pays out 21.90% of its income as dividend. This is a sustainable payout ratio.
The dividend of ALNSE is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP21.9%
EPS Next 2Y21.28%
EPS Next 3YN/A
ALNSE.PA Yearly Income VS Free CF VS DividendALNSE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M
ALNSE.PA Dividend Payout.ALNSE.PA Dividend Payout, showing the Payout Ratio.ALNSE.PA Dividend Payout.PayoutRetained Earnings

NSE

EPA:ALNSE (7/18/2025, 7:00:00 PM)

47

+0.4 (+0.86%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)02-14 2025-02-14/amc
Earnings (Next)N/A N/A
Inst Owners20.28%
Inst Owner ChangeN/A
Ins Owners64.28%
Ins Owner ChangeN/A
Market Cap158.86M
Analysts40
Price Target51.31 (9.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.58%
Yearly Dividend0.25
Dividend Growth(5Y)22.6%
DP21.9%
Div Incr Years2
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)72.26%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-13.76%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 41.23
Fwd PE 25.07
P/S 1.53
P/FCF 14.1
P/OCF 11.19
P/B 3.81
P/tB 4.34
EV/EBITDA 13.84
EPS(TTM)1.14
EY2.43%
EPS(NY)1.87
Fwd EY3.99%
FCF(TTM)3.33
FCFY7.09%
OCF(TTM)4.2
OCFY8.94%
SpS30.64
BVpS12.35
TBVpS10.83
PEG (NY)1.64
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.15%
ROE 8.69%
ROCE 14.62%
ROIC 10.97%
ROICexc 15.46%
ROICexgc 18.16%
OM 6.85%
PM (TTM) 3.5%
GM 43.87%
FCFM 10.88%
ROA(3y)4.86%
ROA(5y)5.44%
ROE(3y)9.24%
ROE(5y)10.68%
ROIC(3y)9.24%
ROIC(5y)10.98%
ROICexc(3y)11.65%
ROICexc(5y)13.8%
ROICexgc(3y)13.37%
ROICexgc(5y)15.81%
ROCE(3y)12.32%
ROCE(5y)14.64%
ROICexcg growth 3Y-2.2%
ROICexcg growth 5Y-7.13%
ROICexc growth 3Y-2.56%
ROICexc growth 5Y-7.79%
OM growth 3Y-10.36%
OM growth 5Y-11.66%
PM growth 3Y-17.04%
PM growth 5Y-14.59%
GM growth 3Y-13.53%
GM growth 5Y-7.43%
F-Score5
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 0.65
Debt/EBITDA 0.49
Cap/Depr 86.46%
Cap/Sales 2.83%
Interest Coverage 41.27
Cash Conversion 135.38%
Profit Quality 310.87%
Current Ratio 1.77
Quick Ratio 1.31
Altman-Z 4.53
F-Score5
WACC7.78%
ROIC/WACC1.41
Cap/Depr(3y)97.38%
Cap/Depr(5y)100.98%
Cap/Sales(3y)3.76%
Cap/Sales(5y)3.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.26%
EPS 3Y-3.88%
EPS 5Y-9.31%
EPS Q2Q%-59.8%
EPS Next Y25.09%
EPS Next 2Y21.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)34.51%
Revenue growth 3Y15.84%
Revenue growth 5Y6.37%
Sales Q2Q%16.05%
Revenue Next Year33.7%
Revenue Next 2Y17.73%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.7%
EBIT growth 3Y3.84%
EBIT growth 5Y-6.03%
EBIT Next Year110.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y363.17%
FCF growth 3Y-2.62%
FCF growth 5Y6.82%
OCF growth 1Y106.8%
OCF growth 3Y-2.36%
OCF growth 5Y8.53%